Reyes Financial Architecture’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
FCM
AIM
NAMA
AVM
BG
Reyes Financial Architecture's BEAM Position: Q2 2025 in Review
Reyes Financial Architecture sold out of Beam Therapeutics (BEAM) in Q2 2025, closing a stake of 150 shares — an estimated $2.93K sold.
Reyes Financial Architecture first reported a position in BEAM in Q1 2025 and held it in 1 quarter. The position peaked at $2.93K in Q1 2025. 216 funds tracked by Wall St. Rank hold BEAM as of Q2 2025.
- Reyes Financial Architecture reported no remaining Beam Therapeutics position as of Q2 2025 after selling out during the quarter.
- Reyes Financial Architecture sold 150 Beam Therapeutics shares in Q2 2025, an estimated $2.93K.
- Reyes Financial Architecture first reported a position in Beam Therapeutics in Q1 2025 and held it in 1 quarter.
- Reyes Financial Architecture's Beam Therapeutics position peaked at $2.93K in Q1 2025.
- 216 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2025.
Based on Reyes Financial Architecture's 13F filing for Q2 2025, filed 9 Jul 2025.